Haemonetics Q4 Profit Tops Estimates - Quick Facts

(RTTNews) - Haemonetics Corp. (HAE) reported fourth quarter adjusted net income of $20.4 million, up 8%, and adjusted earnings per share of $0.39, up 5%, compared to the prior year quarter. On average, nine analysts polled by Thomson Reuters expected the company to report profit per share of $0.38 for the quarter. Analysts' estimates typically exclude special items. The company reported a fourth quarter net loss of $51.1 million or $0.98 per share.

Haemonetics reported fourth-quarter revenue of $228.1 million, down 6% compared to the fourth quarter of fiscal 2016 and down 5% in constant currency. The prior year fourth quarter included a 14th week, which was estimated to decrease the revenue growth rate by 6% in the fourth quarter of fiscal 2017. Analysts expected revenue of $219.42 million for the quarter.

The company expects fiscal 2018 adjusted earnings per share of $1.55 - $1.65. Overall fiscal 2018 revenue is expected to approximate fiscal 2017 revenue.